在患有Hb S/β0-血病的患者中发生了Splice受体突变[HBB:c.93-2A > T]
John S Waye1,2, Meredith Hanna1, Lisa Nakamura1
1Molecular Genetics Laboratory, Hamilton Regional Laboratory Medicine Program, Hamilton Health Sciences, Hamilton, Canada.
Hemoglobin
|February 15, 2024
概括
这项研究详细介绍了一种新型的状细胞β-零-血病病例. 一个患有状细胞突变和结合受体位突变的患者显示出一种新的β-零-thalassemia的原因.
科学领域:
- 血液学 血液学 血液学
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 状细胞病和血病是常见的遗传性血液疾病.
- 贝塔-零-thalassemia导致功能性血红蛋白β链的完全缺失.
- 影响血红蛋白合成的基因突变对于理解这些条件至关重要.
研究的目的:
- 报告一例状细胞β-零-血病 (Hb S/β0-thal) 的新型复合异质合体病例.
- 为了表征HBB基因IVS1拼接受体位的特定突变.
- 为了解导致β-零-thalassemia的遗传变异作出贡献.
主要方法:
- 基因测序用于识别HBB基因中的突变.
- 分析患者的血红蛋白组成.
- 审查关于HBB基因突变和拼接的现有文献.
主要成果:
- 这位患者是Hb Sickle突变 (HBB:c.20A>T) 和一种新的IVS1拼接受体突变 (HBB:c.93-2A>T) 的复合异构体.
- 鉴定的突变 (AG>TG) 破坏了HBB基因的正常拼接.
- 这是第五次报告影响IVS1 AG拼接受体位点的突变,所有这些都导致β-零-thalassemia.
结论:
- 这种情况扩大了导致Hb S/β0-thal. 的已知突变谱.
- IVS1拼接受体部位是正常HBB基因拼接的关键区域.
- 了解这些突变对于遗传咨询和潜在的治疗策略至关重要.
相关概念视频
02:18Alternative RNA Splicing
21.2K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.2K
01:49Multiple Allele Traits
34.2K
The Concept of Multiple Allelism
34.2K
01:31Translation
142.0K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
142.0K
01:22Bone Marrow Sampling and Transplants
330
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
330
01:32RNA Splicing
56.4K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.4K
01:39Mutations
82.2K
Overview
82.2K